These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 33312391)

  • 1. Clinical effects and molecular mechanisms of lncRNA MNX1-AS1 in malignant tumors.
    Shen S; Zhou H
    Am J Transl Res; 2020; 12(11):7593-7602. PubMed ID: 33312391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA MNX1-AS1: A novel oncogenic propellant in cancers.
    Li T; Zhou S; Yang Y; Xu Y; Gong X; Cheng Y; Wang Y
    Biomed Pharmacother; 2022 May; 149():112801. PubMed ID: 35290890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA MNX1-AS1 promotes progression of esophageal squamous cell carcinoma by regulating miR-34a/SIRT1 axis.
    Chu J; Li H; Xing Y; Jia J; Sheng J; Yang L; Sun K; Qu Y; Zhang Y; Yin H; Wan J; He F
    Biomed Pharmacother; 2019 Aug; 116():109029. PubMed ID: 31170665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long Noncoding RNA MNX1-AS1 Knockdown Inhibits Cell Proliferation and Migration in Ovarian Cancer.
    Lv Y; Li H; Li F; Liu P; Zhao X
    Cancer Biother Radiopharm; 2017 Apr; 32(3):91-99. PubMed ID: 28414551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulated expression of MNX1-AS1 long noncoding RNA predicts poor prognosis in gastric cancer.
    Zhang W; Huang L; Lu X; Wang K; Ning X; Liu Z
    Bosn J Basic Med Sci; 2019 May; 19(2):164-171. PubMed ID: 30821221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and significance of LncRNA MNX1-AS1 in non-small cell lung cancer.
    Liu G; Guo X; Zhang Y; Liu Y; Li D; Tang G; Cui S
    Onco Targets Ther; 2019; 12():3129-3138. PubMed ID: 31118668
    [No Abstract]   [Full Text] [Related]  

  • 7. lncRNA MNX1-AS1 Promotes Glioblastoma Progression Through Inhibition of miR-4443.
    Gao Y; Xu Y; Wang J; Yang X; Wen L; Feng J
    Oncol Res; 2019 Feb; 27(3):341-347. PubMed ID: 29678219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long noncoding RNA MNX1-AS1 overexpression promotes the invasion and metastasis of gastric cancer through repressing CDKN1A.
    Ma JX; Yang YL; He XY; Pan XM; Wang Z; Qian YW
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4756-4762. PubMed ID: 31210302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA MNX1-AS1 promotes hepatocellular carcinoma proliferation and invasion through targeting miR-218-5p/COMMD8 axis.
    Ji D; Wang Y; Sun B; Yang J; Luo X
    Biochem Biophys Res Commun; 2019 Jun; 513(3):669-674. PubMed ID: 30982576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA MNX1-AS1 promotes migration and invasion of esophageal squamous cell carcinoma by upregulating IGF2.
    Zheng DN; Zhang CJ; Sun GP
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6179-6185. PubMed ID: 31364117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA MNX1-AS1 promotes the progression of cervical cancer through activating MAPK pathway.
    Liu X; Yang Q; Yan J; Zhang X; Zheng M
    J Cell Biochem; 2019 Mar; 120(3):4268-4277. PubMed ID: 30302806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of long non-coding RNA AFAP1-AS1 in human malignant tumors.
    Ji D; Zhong X; Jiang X; Leng K; Xu Y; Li Z; Huang L; Li J; Cui Y
    Pathol Res Pract; 2018 Oct; 214(10):1524-1531. PubMed ID: 30173945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of lncRNA MNX1-AS1 is associated with poor clinical outcome in epithelial ovarian cancer.
    Li AH; Zhang HH
    Eur Rev Med Pharmacol Sci; 2017 Dec; 21(24):5618-5623. PubMed ID: 29271994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long Noncoding RNA MNX1 antisense RNA 1 Exerts Oncogenic Functions in Bladder Cancer by Regulating miR-218-5p/RAB1A Axis.
    Wang J; Xing H; Nikzad AA; Liu B; Zhang Y; Li S; Zhang E; Jia Z
    J Pharmacol Exp Ther; 2020 Mar; 372(3):237-247. PubMed ID: 31843814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of LncRNA MNX1-AS1/PPFIA4 Activates AKT/HIF-1
    Sun Q; Gui Z; Zhao Z; Xu W; Zhu J; Gao C; Zhao W; Hu H
    J Oncol; 2022; 2022():8303409. PubMed ID: 36226248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long Non-Coding RNA MNX1-AS1 Promotes Progression of Triple Negative Breast Cancer by Enhancing Phosphorylation of Stat3.
    Li J; Li Q; Li D; Shen Z; Zhang K; Bi Z; Li Y
    Front Oncol; 2020; 10():1108. PubMed ID: 32754442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long noncoding RNA MNX1-AS1 contributes to lung cancer progression through the miR-527/BRF2 pathway.
    Liu H; Han L; Liu Z; Gao N
    J Cell Physiol; 2019 Aug; 234(8):13843-13850. PubMed ID: 30618167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MNX1-AS1 is a functional oncogene that induces EMT and activates the AKT/mTOR pathway and MNX1 in breast cancer.
    Cheng Y; Pan Y; Pan Y; Wang O
    Cancer Manag Res; 2019; 11():803-812. PubMed ID: 30697072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MNX1-AS1 is a novel biomarker for predicting clinical progression and poor prognosis in lung adenocarcinoma.
    Yang R; Wang L; Han M
    J Cell Biochem; 2019 May; 120(5):7222-7228. PubMed ID: 30506837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncogenic roles and mechanisms of lncRNA AGAP2-AS1 in human solid tumors.
    Bao Z; Zheng Q; Li L
    Am J Transl Res; 2021; 13(2):757-769. PubMed ID: 33594324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.